Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 12 Lymphoma, Non-Hodgkin 7 Carcinoma, Non-Small-Cell Lung 5 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Recurrence 3 Melanoma 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Urinary Bladder Neoplasms 2 Lymphoma, Follicular 2 Cytokine Release Syndrome 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Liver Cancers × tocilizumab × 1 year × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡